Sands Capital Life Sciences Pulse Fund II, 10% Owner of Inhibikase Therapeutics IKT, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $3M. The latest trade was on 25/11/21.

SI

SI

Sands Capital Life Sciences Pulse Fund II

10% Owner

Company

Inhibikase Therapeutics IKT

First filing

25/11/24

Trades

1 trades

Buys / sales

1 / 0

12-month net buying

$3M

Last trade

25/11/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Inhibikase TherapeuticsIKT	Open-market buy	25/11/21	25/11/24	2,068,965 sh	$1.45	$2,999,999.25	+18.9%